Premier Inc header image

Premier Inc

PINC

Equity

ISIN null / Valor 22227168

NASDAQ (2025-11-17)
USD 28.19%

Premier Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Premier Inc. (NASDAQ: PINC) is a technology-focused healthcare improvement company that serves around two-thirds of U.S. healthcare providers. The company facilitates collaboration among providers, suppliers, payers, and policymakers, aiming to enhance healthcare delivery through data-driven insights and innovative technologies. By leveraging its extensive national presence and actionable intelligence, Premier supports the evolving needs of the healthcare industry, helping to improve efficiency and outcomes across various healthcare settings.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (11.10.2025):

Premier Inc reported its fiscal-year 2025 fourth-quarter financial results for the quarter ended June 30, 2025, demonstrating stronger-than-expected revenue and robust cash generation. The company also provided optimistic guidance for fiscal-year 2026, reflecting confidence in continued growth and profitability.

Total Net Revenue

In the fourth quarter of fiscal-year 2025, Premier Inc achieved total net revenue of $262.9 million, surpassing the company’s expectations. Excluding Contigo Health, net revenue was $258.0 million, indicating solid performance despite market challenges.

Net Income and Earnings Per Share

The fourth-quarter GAAP net income from continuing operations was $18.0 million, or $0.22 per fully diluted share. Additionally, the adjusted EPS excluding Contigo Health* was $0.46, contributing to a full-year adjusted EPS that exceeded the high end of the company’s guidance range.

Cash Flow

Premier Inc generated $417.8 million in net cash from operating activities and achieved free cash flow of $180.5 million for the full year, both of which were better than anticipated. This strong cash performance underscores the company’s effective financial management.

Fiscal-Year 2026 Guidance

The company provided financial guidance for fiscal-year 2026, projecting total net revenue excluding Contigo Health between $940 million and $1 billion. Additionally, adjusted EBITDA is expected to range from $230 million to $245 million, with adjusted EPS projected between $1.33 and $1.43, reflecting continued growth and profitability.

Summarized from source with an LLMView Source

Key figures

25.4%1Y
-12.1%3Y
-18.0%5Y

Performance

29.7%1Y
28.9%3Y
26.3%5Y

Volatility

Market cap

2331 M

Market cap (USD)

Daily traded volume (Shares)

696,966

Daily traded volume (Shares)

1 day high/low

21.73 / 20.955

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Bio-Rad Laboratories, Inc. Class B
Bio-Rad Laboratories, Inc. Class B Bio-Rad Laboratories, Inc. Class B Valor: 912794
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.18%USD 310.70
Glaukos Corp
Glaukos Corp Glaukos Corp Valor: 28262610
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.81%USD 88.40
agilon health inc
agilon health inc agilon health inc Valor: 110653729
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.75%USD 0.54
M1 Kliniken AG
M1 Kliniken AG M1 Kliniken AG Valor: 29694419
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.71%EUR 15.54
Perrigo Company PLC
Perrigo Company PLC Perrigo Company PLC Valor: 22008864
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.60%USD 13.56
Evolent Health Inc
Evolent Health Inc Evolent Health Inc Valor: 28153126
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-7.42%USD 3.87
Pfizer Inc
Pfizer Inc Pfizer Inc Valor: 962004
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.08%USD 25.08
Abbott Laboratories
Abbott Laboratories Abbott Laboratories Valor: 903037
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.43%USD 130.03
Estee Lauder Companies Inc
Estee Lauder Companies Inc Estee Lauder Companies Inc Valor: 99350
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.37%USD 86.09
HCA Healthcare Inc
HCA Healthcare Inc HCA Healthcare Inc Valor: 11321027
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.94%USD 477.10